Indonesian Social Media Celebrity Suspected in Drug Case

Regulations by 2FIRSTS.ai
Apr.24.2024
Indonesian Social Media Celebrity Suspected in Drug Case
Indonesian influencer Chandrika Chika is a suspect in a drug case for using marijuana-flavored e-cigarettes, police investigate.

According to a report by the Indonesian Jakarta media Viva on April 23, Indonesian internet celebrity Chandrika Chika has officially become a suspect in a drug case for using an e-cigarette with a marijuana flavor, prompting an investigation by the police.

 

Deputy Chief of the Drug Unit of the South Jakarta Police Department Rezka Anugras revealed that the department has found evidence including e-cigarettes. Police officials stated that the e-cigarettes confiscated contained marijuana and THC substances. In a hotel located in the Setiabudi district of Kuningan, police successfully apprehended six suspects including Chandrika Chika.

 

Deputy Director of the Drug Unit at the South Jakarta Police Precinct, Rezka Anugras, stated, "The evidence we found on the scene was an e-cigarette or a container filled with e-liquid containing marijuana or THC substances." He went on to say, "Firstly, we have tested the evidence we seized and the e-liquid is being sent to the laboratory for analysis, which has shown it contains marijuana."

 

The public security department has officially listed Chandrika Chika and five others as suspects in a drug case. These suspects are between the ages of 22 and 27, including the internet celebrity Chandrika Chika. Rezka has listed the initials of the suspects involved in the drug case as AT (24), MJ (22), AMO (22), BB (25) and AJ (27). All six individuals are suspected of using marijuana e-cigarettes in a hotel. Currently, the e-cigarettes involved in the case have been sent to the laboratory for testing, and preliminary results show that they contain marijuana elements.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
2Firsts Outlines 2026 Global Product Trends in the New Tobacco Industry
2Firsts Outlines 2026 Global Product Trends in the New Tobacco Industry
As regulation tightens and innovation matures, competition in the new tobacco industry is shifting. In its 2026 Global Product Trends in the New Tobacco Industry report, 2Firsts examines how heated tobacco, nicotine pouches, and vape products are moving beyond feature-driven upgrades toward system-level design, where experience management, compliance structure, and engineering capability increasingly shape long-term competition.
Jan.13 by 2Firsts Perspectives
Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania’s Competition Council has found that Philip Morris Trading SRL and two distributors engaged in agreements to fix resale prices and promotional discounts for IQOS heated tobacco products.
Dec.19 by 2FIRSTS.ai
British American Tobacco Introduces Facial Age Verification in Italy, Pilot Covers 119 Stores
British American Tobacco Introduces Facial Age Verification in Italy, Pilot Covers 119 Stores
British American Tobacco’s Italian unit is partnering with digital identity firm Yoti to pilot facial-scan age verification at 119 pop-up stores nationwide, aiming to supplement traditional ID checks and prevent underage purchases of tobacco and nicotine products.
Dec.25 by 2FIRSTS.ai
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20